A Randomized, Blind, Parallel Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy People Aged 2 Years and Older
Vaccine（2024）
关键词
Streptococcus pneumoniae,Safety,Immunogenicity,23-valent pneumococcal polysaccharide vaccine,Clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要